Lawrenceville, NJ, United States of America

Cameron James Smith

USPTO Granted Patents = 19 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 15 (Patent Applications = 6)

Average Co-Inventor Count = 8.6

ph-index = 6

Forward Citations = 114(Granted Patents)

Location History:

Lawrenceville, NJ (US) (2010 - 2018)
Montgomery Village, MD (US) (2017 - 2019)

Company Filing History:

18 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 227

Mochida Pharmaceutical Co., Ltd.

Mochida Pharmacuetical Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2010-2019

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10428076 - Soluble guanylate cyclase stimulators (2019-10-01),

2. 10030027 - Soluble guanylate cyclase stimulators (2018-07-24),

3. 9969724 - Factor IXa inhibitors (2018-05-15),

4. 9914727 - Factor IXa inhibitors (2018-03-13),

5. 9808445 - Factor IXa inhibitors (2017-11-07),

6. 9717714 - Spirocyclic CETP inhibitors (2017-08-01),

7. 9708308 - Factor IXa inhibitors (2017-07-18),

8. 9695198 - Factor IXa inhibitors (2017-07-04),

9. 9365574 - Soluble guanylate cyclase activators (2016-06-14),

10. 9221834 - Cyclic amine substituted oxazolidinone CETP inhibitor (2015-12-29),

11. 8735435 - CETP inhibitors (2014-05-27),

12. 8440702 - 1,3-oxazolidin -2-one derivatives useful as CETP inhibitors (2013-05-14),

13. 8354454 - Prodrugs of oxazolidinone CETP inhibitors (2013-01-15),

14. 8334290 - CETP inhibitors (2012-12-18),

15. 7915271 - 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors (2011-03-29),

Title: The Innovative Contributions of Cameron James Smith

Introduction

Cameron James Smith, based in Lawrenceville, NJ, is a prolific inventor with an impressive portfolio of 19 patents. His innovative work primarily focuses on the development of pharmaceutical compounds aimed at improving health outcomes through the modulation of biochemical pathways.

Latest Patents

Smith's latest patents revolve around soluble guanylate cyclase stimulators. These inventions provide compounds that can modulate the body's production of cyclic guanosine monophosphate (cGMP). This modulation is essential for the therapy and prophylaxis of diseases associated with a disturbed cGMP balance. In addition, his patents encompass pharmaceutical compositions comprising these compounds and methods for their use in therapies and for preparing pharmaceuticals.

Career Highlights

Throughout his career, Cameron has worked with notable companies, including Merck Sharp & Dohme Corporation and Mochida Pharmaceutical Co., Ltd. His contributions to these organizations demonstrate his commitment to advancing healthcare through innovative means.

Collaborations

Cameron has collaborated with talented professionals in the field, such as Yi-Heng Chen and Amjad Ali. These partnerships have resulted in significant advancements in pharmaceutical research and development.

Conclusion

Cameron James Smith's work exemplifies the spirit of innovation and dedication to improving public health. With 19 patents to his name, his contributions to the world of pharmaceutical sciences are poised to make a lasting impact.

This text is generated by artificial intelligence and may not be accurate.